IMARC Group’s latest research report, titled “Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027 exhibiting a CAGR of 11.20% during 2022-2027.
Cancer/tumor profiling, or biomarker testing, is a laboratory test for identifying specific proteins, genes or gene mutations, and other biomarkers in a tumor tissue sample. It helps oncologists determine whether the pathways of an individual’s tumor match up with the available targeted therapies. It also assists in routine diagnostics, therapeutic decision-making, and creating personalized treatment plans and therapies for patients according to the severity of their ailment and genomic build-up. As a result, cancer/tumor profiling finds extensive applications in research, biomarker discovery, developing screening and diagnostic techniques, and personalized medicine.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/cancer-tumor-profiling-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by cancer type, technology, technique, application and region.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Cancer/Tumor Profiling Market
- Strategies of major players and product offerings
The global cancer/tumor profiling market is primarily driven by the rising prevalence of cancer. Additionally, there has been widespread product adoption in the oncology research and discovery of biomarkers during the drug design, discovery and development process. In line with this, the rising government funding and support for developing innovative techniques to decrease the time taken for tumor detection and identification is another major growth-inducing factor. Furthermore, extensive investments in research and development (R&D) activities by pharmaceutical and biotechnology companies to introduce novel therapies and new drug designing techniques have catalyzed market growth. Other factors, including the increasing clinical trials, growing adoption of immunoassay techniques, escalating demand for personalized medicine, the recent innovations in molecular biology techniques, including next-generation sequencing, and improving healthcare infrastructure, are also anticipated to drive the market further.
Key Players Included in Global Research Report:
- Abbott Laboratories
- Becton Dickinson and Company
- Caris Life Sciences
- Exact Sciences Corporation
- Hoffmann-La Roche Ltd
- Hologic Inc.
- HTG Molecular Diagnostics Inc.
- Illumina Inc.
- Laboratory Corporation of America Holdings
- NeoGenomics Laboratories
- Qiagen N.V.
- Siemens AG
- Sysmex Corporation.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/cancer-tumor-profiling-market
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Segmentation:
Breakup by Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
- Others
Breakup by Technology:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In-Situ Hybridization (ISH)
- Microarray
- Others
Breakup by Technique:
- Genomics
- Proteomics
- Epigenetics
- Metabolomics
Breakup by Application:
- Personalized Medicine
- Diagnostics
- Biomarker Discovery
- Prognostics
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
TOC for the Cancer/Tumor Profiling Market Research Report:
- Preface
- Scope and Methodology
- Executive Summary
- Introduction
- Global Cancer/Tumor Profiling Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800